
    
      The aim of this protocol is to assess the efficacy, safety and performance of Venus P-valve.

      Patients between 18-60 years with RVOT stenosis and moderate to severe pulmonary
      regurgitation (â‰¥3+) who have undergone trans-annular patch repair of their RVOT, cardiac
      magnetic resonance (CMR) screening right ventricular end-diastolic volume index (RVEDVI)
      between 130-160mL/m2.

      Post-procedure follow-ups will be scheduled at 24 hours, 30 days, 6 months and 12 months.
    
  